What is Avarint?
Avarint is a client-focused entity dedicated to advancing research, development, testing, and systems integration, with a pronounced commitment to innovation and cutting-edge technology. The company distinguishes itself through independent third-party testing services in chemical and biological sciences, alongside the development of sophisticated modeling and simulation systems tailored for C4ISR applications. As a subsidiary of CUBRC, Inc., Avarint benefits from a rich legacy of over 40 years in engineering and testing expertise, enabling it to deliver bespoke solutions that precisely address client requirements and ensure timely, thorough responses.
How much funding has Avarint raised?
Avarint has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Avarint
PPP
Public-Private Partnership
What's next for Avarint?
The substantial enterprise-level funding and recent strategic investment signal a pivotal phase for Avarint. This capital infusion is likely to accelerate the company's innovation pipeline, enhance its research and development capabilities, and potentially expand its market reach in specialized areas like C4ISR systems. The backing from strategic partners suggests a focus on strengthening existing technological advantages and exploring new avenues for growth and application of its testing and integration services.
See full Avarint company page
